Breast cancer is the most common type of cancer in women, but men can also be diagnosed with the disease.
How common is breast cancer in men?
While male breast cancer is rare, according to the National Cancer Institute about 2,000 men will receive this diagnosis every year, or less than 1% of all new breast cancer cases.
While researchers can’t say for certain why breast cancer is rare for men and more prevalent in women, they believe it has to do with breast development. Due in part to the hormones estrogen and progesterone, a female breast is typically more developed than a male breast. Men have less breast tissue and their breast cells divide more infrequently, resulting in a decreased chance that one will become malignant.
What are the risk factors for men with breast cancer?
Many risk factors are common to everyone. Some are modifiable and related to lifestyle. Factors include:
- Age (the risk of getting cancer increases with age)
- Heavy alcohol intake
- Living a sedentary lifestyle (one that involves little or no physical activity)
What are the symptoms of breast cancer that men should know?
Because men can develop breast cancer, it’s important to be aware of the warning signs, including breast lumps.
“Men will often feel a lump, but since they don’t have the knowledge that breast cancer can happen to them, they may ignore it, and believe it will just go away,” adds Jose Pablo Leone, MD. “It’s important to remain vigilant and make sure you are aware of the warning signs.”
If you experience any of the following signs, be sure to consult with a doctor:
- A lump or swelling in or near the breast, underarm area, or around the collar bone
- Dimpled skin around the breast
- A change in the size or shape of the breast
- The nipple turning inward
- Redness, scaling, or swollen skin on the breast, nipple, or areola (dark area of skin around the nipple)
- Nipple discharge, especially if it is bloody
- Peau d’orange: dimples in the breast that look like the skin of an orange
Even if you are experiencing one or more of these symptoms, you do not necessarily have breast cancer. However, you should still discuss any changes in your body with your doctor.
What are the types of breast cancer?
Breast cancer falls into one of three subtypes:
- Hormone receptor-positive breast cancer (HR+), meaning the cancer cells have either estrogen or progesterone receptors
- HER2-positive breast cancer, indicating the cancer has excessive amounts of the HER2 receptor
- Triple-negative breast cancer, used to describe cancer that lacks any of the previous receptors
Most men who are diagnosed with breast cancer (85%) will have hormone receptor-positive (HR+) breast cancer. 10-12% will have HER2-positive breast cancer, while triple-negative male breast cancer occurs in just 2-3% of cases.
What are the stages of breast cancer?
Breast cancers are staged on a scale from zero to four. The lower the number, the less the cancer has spread.
- Stage 0 breast cancer is a non-invasive condition. Stage 0 breast cancers include ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). These diseases are not considered life-threatening but can become invasive over time if not appropriately treated. Both increase the risk of developing breast cancer in the future.
- Stage I cancer usually involves a tumor that is two centimeters or smaller and has not spread outside the breast. Stage I cancers are most often curable.
- Stage II and III cancer includes medium- to larger-sized tumors as well as tumors with positive lymph nodes. With advances in breast care treatment, stage II and stage III cancers are often curable, but may require additional treatments to achieve this goal.
- In stage IV, the cancer has spread to other organs of the body, most often the bones, lungs, or liver. Another name for stage IV breast cancer is metastatic breast cancer.
Most often, men are diagnosed with breast cancer at later stages than women. One reason for this is that men don’t receive routine mammograms, so doctors have to rely on symptoms to spot the disease. Patients may not exhibit symptoms until after the tumor has grown enough.
There has been much debate as to whether men should also undergo routine mammograms to screen for breast cancer. Currently, due to the rarity of this disease in men and the risks of mammograms, the test is not typically offered to men.
Treatment for male breast cancer
Breast cancer patients will typically undergo a combination of surgery, chemotherapy, hormone therapy (if appropriate), and radiation. Although the general outline is similar for all patients, there are two key differences between how breast cancer is treated:
- First, while women are often given the option of either a mastectomy (complete removal of the breast) or a combination of a lumpectomy (removal of the tumor and some of the normal tissue surrounding it) and radiation, most men will undergo a mastectomy. Male breast tumors are generally larger, and men have smaller breasts than women.
- Secondly, men may not have access to the same array of clinical trials that women do. Due to the rarity of this disease, there are currently very few clinical trials that are dedicated to exploring male breast cancer exclusively. While many believe the same drugs that are effective in women will also work in men, it’s dangerous to make assumptions without knowledge, according to Leone. In 2019, the FDA issued a draft guidance advocating for more breast cancer trials to be opened to male participants.
Researchers like Leone are constantly working to learn more about the causes of male breast cancer, devise optimal treatments, and understand the side effects these treatments have. In addition, all breast cancer patients at Dana-Farber are allowed to enroll in the Institute’s breast cancer trials, unless there is a specific medical reason they can’t (i.e., studying how a therapy affects pregnant women).
About the Medical Reviewer
Dr. Leone received his MD from Universidad del Salvador, Argentina in 2005. He completed his residency in Internal Medicine at University of Miami Jackson Memorial Hospital in 2011, and went on to complete fellowships in Hematology and Medical Oncology at University of Pittsburgh Medical Center in 2014. He was faculty at University of Iowa Hospitals and Clinics from 2014 through 2017. In 2017, he joined the staff of Brigham and Women's Hospital and Dana-Farber, where he is a medical oncologist and clinical investigator in the Breast Oncology Center. His research focuses on brain metastases, male breast cancer and novel therapies in the treatment of breast cancer.